The global fibromyalgia treatment market is projected to expand from USD 2.77 billion in 2023 to approximately USD 4.13 billion by 2032, growing at a compound annual growth rate (CAGR) of 4.3% from 2024 to 2032.
Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5139
Fibromyalgia affects around 4 million adults in the United States, roughly 2% of the adult population. While the exact cause remains unknown, effective treatment options are available. As the need for these treatments grows, researchers are exploring new approaches beyond traditional medications.
Fibromyalgia is characterized by widespread muscle pain, fatigue, difficulty concentrating, and other emotional and physical symptoms. Although people with fibromyalgia experience pain in muscles and soft tissues, there is no visible inflammation in these areas.
Research suggests that fibromyalgia may be linked to how the body processes pain, a condition known as central sensitization syndrome. It is more common in women, with approximately 6.4% of the U.S. population affected (7.7% in women and 4.9% in men). Studies in Europe and South America show similar rates, ranging from 3.3% to 8.3%. Fibromyalgia is more prevalent as people age, often affecting women between the ages of 20 and 55. Teenagers can also experience fibromyalgia at similar rates as adults, and in specialized pain clinics, over 40% of patients meet the criteria for the condition.
Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/fibromyalgia-treatment-market-sizing
Access exclusive insight now @ https://www.towardshealthcare.com/price/5139
We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com
Web: https://www.towardshealthcare.com
Visit Dental Specifics: https://www.towardsdental.com
Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
Market Overview The global subcutaneous biologics market is on a strong growth trajectory, projected to expand from USD 1.89 billion… Read More
The landscape of Primary Progressive Multiple Sclerosis (PPMS) is on the brink of a transformative decade. With innovative research, strategic… Read More
Market Overview The global needle-free drug delivery devices market is on an impressive growth trajectory. Valued at USD 14.24 billion… Read More
The global thyroid cancer diagnostics market is experiencing steady growth as advancements in medical technologies continue to enhance early detection,… Read More
The global autoimmune disease diagnostics market is poised for significant growth in the coming decade. Market forecasts indicate a surge… Read More
The Europe dermal filler market is witnessing remarkable growth, fueled by rising beauty consciousness, advancements in non-invasive aesthetic procedures, and… Read More